Skip to main content
. 2020 Oct 21;22(3):344–353. doi: 10.3348/kjr.2019.0851

Table 4. The Predicted Tumor Risk Category Results (Number of Patients).

Mitotic Index Training Cohort (n = 108) Validation Cohort (n = 20) Test Cohort (n = 20)
Low-Mitotic High-Mitotic Low-Mitotic High-Mitotic Low-Mitotic High-Mitotic
True 50 50 7 9 8 10
False 4 4 3 1 2 0
Total 54 54 10 10 10 10
Accuracy (95% CI), % 92.6 (0.876–0.976) 80.0 (0.608–0.992) 90.0 (0.756–1.000)
Sensitivity (95% CI), % 92.6 (0.813–0.986) 90.0 (0.541–0.995) 100.0 (0.656–1.000)
Specificity (95% CI), % 92.6 (0.813–0.986) 70.0 (0.354–0.919) 80.0 (0.442–0.965)
Positive predictive value (95% CI), % 92.6 (0.813–0.986) 75.0 (0.428–0.933) 83.3 (0.509–0.971)
Negative predictive value (95% CI), % 92.6 (0.813–0.986) 87.5 (0.467–0.993) 100.0 (0.598–1.000)